ID: ALA5203581

Max Phase: Preclinical

Molecular Formula: C53H81N11O14S2

Molecular Weight: 1160.43

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C

Standard InChI:  InChI=1S/C53H81N11O14S2/c1-9-29(6)43(55)52(77)62-40(26-42(68)69)51(76)59-36(22-27(2)3)47(72)61-39(25-41(54)67)50(75)60-37(23-30-10-14-32(65)15-11-30)49(74)58-35(19-21-80-8)46(71)64-44(28(4)5)53(78)63-38(24-31-12-16-33(66)17-13-31)48(73)57-34(45(56)70)18-20-79-7/h10-17,27-29,34-40,43-44,65-66H,9,18-26,55H2,1-8H3,(H2,54,67)(H2,56,70)(H,57,73)(H,58,74)(H,59,76)(H,60,75)(H,61,72)(H,62,77)(H,63,78)(H,64,71)(H,68,69)/t29-,34-,35-,36-,37-,38-,39-,40-,43-,44-/m0/s1

Standard InChI Key:  RYAYTWNQFRWAKR-RKMJNRQDSA-N

Associated Targets(Human)

MKN-7 272 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MKN-74 303 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1160.43Molecular Weight (Monoisotopic): 1159.5406AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Yoshida J, Takayama K, Kawada M..  (2022)  Short peptides derived from hGAPDH exhibit anti-cancer activity.,  71  [PMID:35964520] [10.1016/j.bmc.2022.116953]

Source